Table of Contents

1 Study Coverage

• 1.1 Penicillin/Streptomycin Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Penicillin/Streptomycin Market Size Growth Rate by Product
  • 1.4.2 Penicillin
  • 1.4.3 Streptomycin
• 1.5 Market by End User
  • 1.5.1 Global Penicillin/Streptomycin Market Size Growth Rate by End User
  • 1.5.2 Hospitals
  • 1.5.3 Clinics
  • 1.5.4 Others
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Penicillin/Streptomycin Market Size
  • 2.1.1 Global Penicillin/Streptomycin Revenue 2014-2025
  • 2.1.2 Global Penicillin/Streptomycin Sales 2014-2025
• 2.2 Penicillin/Streptomycin Growth Rate by Regions
  • 2.2.1 Global Penicillin/Streptomycin Sales by Regions
  • 2.2.2 Global Penicillin/Streptomycin Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Penicillin/Streptomycin Sales by Manufacturers
  • 3.1.1 Penicillin/Streptomycin Sales by Manufacturers
  • 3.1.2 Penicillin/Streptomycin Sales Market Share by Manufacturers
  • 3.1.3 Global Penicillin/Streptomycin Market Concentration Ratio (CR5 and HHI)
• 3.2 Penicillin/Streptomycin Revenue by Manufacturers
  • 3.2.1 Penicillin/Streptomycin Revenue by Manufacturers (2014-2019)
  • 3.2.2 Penicillin/Streptomycin Revenue Share by Manufacturers (2014-2019)
• 3.3 Penicillin/Streptomycin Price by Manufacturers
• 3.4 Penicillin/Streptomycin Manufacturing Base Distribution, Product Types
  • 3.4.1 Penicillin/Streptomycin Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Penicillin/Streptomycin Product Type
  • 3.4.3 Date of International Manufacturers Enter into Penicillin/Streptomycin Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global Penicillin/Streptomycin Sales by Product
• 4.2 Global Penicillin/Streptomycin Revenue by Product
• 4.3 Penicillin/Streptomycin Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global Penicillin/Streptomycin Breakdown Data by End User

6 North America

• 6.1 North America Penicillin/Streptomycin by Countries
  • 6.1.1 North America Penicillin/Streptomycin Sales by Countries
  • 6.1.2 North America Penicillin/Streptomycin Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Penicillin/Streptomycin by Product
• 6.3 North America Penicillin/Streptomycin by End User

7 Europe

• 7.1 Europe Penicillin/Streptomycin by Countries
  • 7.1.1 Europe Penicillin/Streptomycin Sales by Countries
  • 7.1.2 Europe Penicillin/Streptomycin Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Penicillin/Streptomycin by Product
• 7.3 Europe Penicillin/Streptomycin by End User

8 Asia Pacific

• 8.1 Asia Pacific Penicillin/Streptomycin by Countries
  • 8.1.1 Asia Pacific Penicillin/Streptomycin Sales by Countries
  • 8.1.2 Asia Pacific Penicillin/Streptomycin Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific Penicillin/Streptomycin by Product
• 8.3 Asia Pacific Penicillin/Streptomycin by End User

9 Central & South America

• 9.1 Central & South America Penicillin/Streptomycin by Countries
  • 9.1.1 Central & South America Penicillin/Streptomycin Sales by Countries
  • 9.1.2 Central & South America Penicillin/Streptomycin Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America Penicillin/Streptomycin by Product
• 9.3 Central & South America Penicillin/Streptomycin by End User

10 Middle East and Africa

• 10.1 Middle East and Africa Penicillin/Streptomycin by Countries
  • 10.1.1 Middle East and Africa Penicillin/Streptomycin Sales by Countries
  • 10.1.2 Middle East and Africa Penicillin/Streptomycin Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Penicillin/Streptomycin by Product
• 10.3 Middle East and Africa Penicillin/Streptomycin by End User

11 Company Profiles

• 11.1 Johnson & Johnson
  • 11.1.1 Johnson & Johnson Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 Johnson & Johnson Penicillin/Streptomycin Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 Johnson & Johnson Penicillin/Streptomycin Products Offered
  • 11.1.5 Johnson & Johnson Recent Development
• 11.2 Pfizer
  • 11.2.1 Pfizer Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 Pfizer Penicillin/Streptomycin Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 Pfizer Penicillin/Streptomycin Products Offered
  • 11.2.5 Pfizer Recent Development
• 11.3 Bayer HealthCare
  • 11.3.1 Bayer HealthCare Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 Bayer HealthCare Penicillin/Streptomycin Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 Bayer HealthCare Penicillin/Streptomycin Products Offered
  • 11.3.5 Bayer HealthCare Recent Development
• 11.4 Abbot Laboratories
  • 11.4.1 Abbot Laboratories Company Details
  • 11.4.2 Company Business Overview
  • 11.4.3 Abbot Laboratories Penicillin/Streptomycin Sales, Revenue and Gross Margin (2014-2019)
  • 11.4.4 Abbot Laboratories Penicillin/Streptomycin Products Offered
  • 11.4.5 Abbot Laboratories Recent Development
• 11.5 Roche Pharmaceuticals
  • 11.5.1 Roche Pharmaceuticals Company Details
  • 11.5.2 Company Business Overview
  • 11.5.3 Roche Pharmaceuticals Penicillin/Streptomycin Sales, Revenue and Gross Margin (2014-2019)
  • 11.5.4 Roche Pharmaceuticals Penicillin/Streptomycin Products Offered
  • 11.5.5 Roche Pharmaceuticals Recent Development
• 11.6 Sanofi Aventis
  • 11.6.1 Sanofi Aventis Company Details
  • 11.6.2 Company Business Overview
  • 11.6.3 Sanofi Aventis Penicillin/Streptomycin Sales, Revenue and Gross Margin (2014-2019)
  • 11.6.4 Sanofi Aventis Penicillin/Streptomycin Products Offered
  • 11.6.5 Sanofi Aventis Recent Development
• 11.7 Takeda Pharmaceutical Company
  • 11.7.1 Takeda Pharmaceutical Company Company Details
  • 11.7.2 Company Business Overview
  • 11.7.3 Takeda Pharmaceutical Company Penicillin/Streptomycin Sales, Revenue and Gross Margin (2014-2019)
  • 11.7.4 Takeda Pharmaceutical Company Penicillin/Streptomycin Products Offered
  • 11.7.5 Takeda Pharmaceutical Company Recent Development
• 11.8 Toyama Chemical
  • 11.8.1 Toyama Chemical Company Details
  • 11.8.2 Company Business Overview
  • 11.8.3 Toyama Chemical Penicillin/Streptomycin Sales, Revenue and Gross Margin (2014-2019)
  • 11.8.4 Toyama Chemical Penicillin/Streptomycin Products Offered
  • 11.8.5 Toyama Chemical Recent Development
• 11.9 Merck & Co.
  • 11.9.1 Merck & Co. Company Details
  • 11.9.2 Company Business Overview
  • 11.9.3 Merck & Co. Penicillin/Streptomycin Sales, Revenue and Gross Margin (2014-2019)
  • 11.9.4 Merck & Co. Penicillin/Streptomycin Products Offered
  • 11.9.5 Merck & Co. Recent Development
• 11.10 MiddleBrook Pharmaceuticals
  • 11.10.1 MiddleBrook Pharmaceuticals Company Details
  • 11.10.2 Company Business Overview
  • 11.10.3 MiddleBrook Pharmaceuticals Penicillin/Streptomycin Sales, Revenue and Gross Margin (2014-2019)
  • 11.10.4 MiddleBrook Pharmaceuticals Penicillin/Streptomycin Products Offered
  • 11.10.5 MiddleBrook Pharmaceuticals Recent Development
• 11.11 Novartis
• 11.12 Biogen IDEC
• 11.13 Bristol Myers Squibb
• 11.14 Celgine Corporation
• 11.15 Eli Lilly and Co
• 11.16 Gilead Sciences
• 11.17 GlaxoSmithKline
• 11.18 Amgen
• 11.19 Astellas Pharma
• 11.20 Astra Zeneca

12 Future Forecast

• 12.1 Penicillin/Streptomycin Market Forecast by Regions
  • 12.1.1 Global Penicillin/Streptomycin Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Penicillin/Streptomycin Revenue Forecast by Regions 2019-2025
• 12.2 Penicillin/Streptomycin Market Forecast by Product
  • 12.2.1 Global Penicillin/Streptomycin Sales Forecast by Product 2019-2025
  • 12.2.2 Global Penicillin/Streptomycin Revenue Forecast by Product 2019-2025
• 12.3 Penicillin/Streptomycin Market Forecast by End User
• 12.4 North America Penicillin/Streptomycin Forecast
• 12.5 Europe Penicillin/Streptomycin Forecast
• 12.6 Asia Pacific Penicillin/Streptomycin Forecast
• 12.7 Central & South America Penicillin/Streptomycin Forecast
• 12.8 Middle East and Africa Penicillin/Streptomycin Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Penicillin/Streptomycin Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details

The global Penicillin/Streptomycin market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Penicillin/Streptomycin market based on company, product type, end user and key regions.

This report studies the global market size of Penicillin/Streptomycin in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Penicillin/Streptomycin in these regions.
This research report categorizes the global Penicillin/Streptomycin market by top players/brands, region, type and end user. This report also studies the global Penicillin/Streptomycin market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Johnson & Johnson
Pfizer
Bayer HealthCare
Abbot Laboratories
Roche Pharmaceuticals
Sanofi Aventis
Takeda Pharmaceutical Company
Toyama Chemical
Merck & Co.
MiddleBrook Pharmaceuticals
Novartis
Biogen IDEC
Bristol Myers Squibb
Celgine Corporation
Eli Lilly and Co
Gilead Sciences
GlaxoSmithKline
Amgen
Astellas Pharma
Astra Zeneca

Market size by Product
Penicillin
Streptomycin
Market size by End User
Hospitals
Clinics
Others

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Penicillin/Streptomycin market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Penicillin/Streptomycin market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Penicillin/Streptomycin companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Penicillin/Streptomycin submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Penicillin/Streptomycin are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Penicillin/Streptomycin market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.